Hanmi’s Poziotinib proved innovative efficacy for NSCLC patients

October 20, 2017 Posted by Yakup

The advanced clinical result of ‘Poziotinib,’ a novel anticancer drug developed by Hanmi Pharm and licensed to Spectrum Pharmaceuticals, was revealed on the 18th at the World Conference on Lung Cancer(WCLC) in Yokohama, Japan. Dr. John Heymach from the University of Texas MD Anderson...

Inevitable MFDS’s reorganization brought at National Assembly inspection

October 20, 2017 / Posted by Yakup

The National Assembly inspection suggested problems related to the operational system of the Ministry of Food and Drug Safety(MFDS), which basically criticized necessity of reshuffle in the MFDS. ...

Series of administrative measures on multinational pharmas for violating Pharmaceutical Affairs Law

October 20, 2017/ Posted by Yakup

Multinational pharmaceutical companies branching in Korea have frequently received administrative measures, such as sales suspension and advertising suspension, for violating the Pharmaceutical Aff...

“The government must cooperate in eradicating hepatitis”

October 20, 2017/ Posted by Yakup

In order to eradicate viral hepatitis in Korea, it is necessary for the government to pay attention, but the reality was reportedly not. The Korean Association for the Study of the Liver(Chairman ...

Celltrion, “We’re preparing for the U.S. FDA’s onsite inspection for our first global generic”

October 20, 2017/ Posted by Yakup

In response to the Korea Exchange’s request of inquiry notice on the 17th, Celltrion officially announced on the 18th “We carefully reviewed each item on Paragraph 1 of Article 6 of the...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.